;PMID: 2802622
;source_file_893.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..47] = [t:0..47]
;1)sentence:[e:53..123] = [t:53..123]
;2)section:[e:127..150] = [t:127..150]
;3)section:[e:154..202] = [t:154..202]
;4)sentence:[e:206..319] = [t:206..319]
;5)sentence:[e:320..445] = [t:320..445]
;6)sentence:[e:446..628] = [t:446..628]
;7)sentence:[e:629..823] = [t:629..823]
;8)sentence:[e:825..935] = [t:825..935]
;9)sentence:[e:936..1317] = [t:936..1317]
;10)sentence:[e:1318..1518] = [t:1318..1518]
;11)sentence:[e:1519..1634] = [t:1519..1634]
;12)section:[e:1638..1682] = [t:1638..1682]

;section 0 Span:0..47
;Arch Biochem Biophys. 1989 Nov 1;274(2):471-80.
(SEC
  (FRAG (NNP:[0..4] Arch) (NNP:[5..12] Biochem) (NNP:[13..20] Biophys)
        (.:[20..21] .) (CD:[22..26] 1989) (NNP:[27..30] Nov)
        (CC:[31..37] 1;274-LRB-) (CD:[37..38] 2) (-RRB-:[38..39] -RRB-)
        (CD:[39..43] :471) (::[43..44] -) (CD:[44..46] 80) (.:[46..47] .)))

;sentence 1 Span:53..123
;Characterization of heme oxygenase in the small intestinal epithelium.
;[73..87]:substance:"heme oxygenase"
(SENT
  (NP-HLN
    (NP (NN:[53..69] Characterization))
    (PP (IN:[70..72] of)
      (NP
        (NP (NN:[73..77] heme) (NN:[78..87] oxygenase))
        (PP-LOC (IN:[88..90] in)
          (NP (DT:[91..94] the)
            (ADJP (JJ:[95..100] small) (JJ:[101..111] intestinal))
            (NN:[112..122] epithelium)))))
    (.:[122..123] .)))

;section 2 Span:127..150
;Rosenberg DW, Kappas A.
(SEC
  (FRAG (NNP:[127..136] Rosenberg) (NNP:[137..139] DW) (,:[139..140] ,)
        (NNP:[141..147] Kappas) (NN:[148..150] A.)))

;section 3 Span:154..202
;Rockefeller University Hospital, New York 10021.
(SEC
  (FRAG (NNP:[154..165] Rockefeller) (NNP:[166..176] University)
        (NNP:[177..185] Hospital) (,:[185..186] ,) (NNP:[187..190] New)
        (NNP:[191..195] York) (.:[196..201] 10021) (.:[201..202] .)))

;sentence 4 Span:206..319
;Heme oxygenase activity was examined in the epithelial cells of the small 
;intestine in male Sprague-Dawley rats.
;[206..220]:substance:"Heme oxygenase"
(SENT
  (S
    (NP-SBJ-1
       (NN:[206..210] Heme) (NN:[211..220] oxygenase)
      (NN:[221..229] activity))
    (VP (VBD:[230..233] was)
      (VP (VBN:[234..242] examined)
        (NP-1 (-NONE-:[242..242] *))
        (PP-LOC (IN:[243..245] in)
          (NP
            (NP (DT:[246..249] the) (JJ:[250..260] epithelial)
                (NNS:[261..266] cells))
            (PP (IN:[267..269] of)
              (NP (DT:[270..273] the) (JJ:[274..279] small)
                  (NN:[281..290] intestine)))))
        (PP (IN:[291..293] in)
          (NP (JJ:[294..298] male)
            (NML (NNP:[299..306] Sprague) (HYPH:[306..307] -)
                 (NNP:[307..313] Dawley))
            (NNS:[314..318] rats)))))
    (.:[318..319] .)))

;sentence 5 Span:320..445
;As with liver and spleen, the highest  specific activity of this enzyme was
;found in the microsomal fraction of these  cells.
;[385..391]:substance:"enzyme"
(SENT
  (S
    (PP (IN:[320..322] As)
      (PP (IN:[323..327] with)
        (NP (NN:[328..333] liver) (CC:[334..337] and) (NN:[338..344] spleen))))
    (,:[344..345] ,)
    (NP-SBJ-1
      (NP (DT:[346..349] the) (JJS:[350..357] highest) (JJ:[359..367] specific)
          (NN:[368..376] activity))
      (PP (IN:[377..379] of)
        (NP (DT:[380..384] this) (NN:[385..391] enzyme))))
    (VP (VBD:[392..395] was)
      (VP (VBN:[396..401] found)
        (NP-1 (-NONE-:[401..401] *))
        (PP-LOC (IN:[402..404] in)
          (NP
            (NP (DT:[405..408] the) (JJ:[409..419] microsomal)
                (NN:[420..428] fraction))
            (PP (IN:[429..431] of)
              (NP (DT:[432..437] these) (NNS:[439..444] cells)))))))
    (.:[444..445] .)))

;sentence 6 Span:446..628
;Substrate kinetics, analysis of cofactor requirements, and other  biochemical
;characteristics suggested further similarities between heme  oxygenase in the
;small intestine and liver.
;[446..455]:substance:"Substrate"
;[478..486]:substance:"cofactor"
;[579..594]:substance:"heme  oxygenase"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[446..455] Substrate) (NNS:[456..464] kinetics))
      (,:[464..465] ,)
      (NP
        (NP (NN:[466..474] analysis))
        (PP (IN:[475..477] of)
          (NP (NN:[478..486] cofactor) (NNS:[487..499] requirements))))
      (,:[499..500] ,) (CC:[501..504] and)
      (NP (JJ:[505..510] other) (JJ:[512..523] biochemical)
          (NNS:[524..539] characteristics)))
    (VP (VBD:[540..549] suggested)
      (NP
        (NP (JJ:[550..557] further) (NNS:[558..570] similarities))
        (PP (IN:[571..578] between)
          (NP
            (NP (NN:[579..583] heme) (NN:[585..594] oxygenase))
            (PP-LOC (IN:[595..597] in)
              (NP (DT:[598..601] the)
                (NML
                  (NML (JJ:[602..607] small) (NN:[608..617] intestine))
                  (CC:[618..621] and)
                  (NML (NN:[622..627] liver)))))))))
    (.:[627..628] .)))

;sentence 7 Span:629..823
;Enzyme activity was differentially  localized longitudinally within the small
;intestine, with the highest specific  activity occurring in the region
;approximately 15 to 30 cm beyond the pylorus.
;[629..635]:substance:"Enzyme"
;[792..800]:quantitative-value:"15 to 30"
;[801..803]:quantitative-units:"cm"
(SENT
  (S
    (NP-SBJ-1 (NN:[629..635] Enzyme) (NN:[636..644] activity))
    (VP (VBD:[645..648] was)
      (ADVP (RB:[649..663] differentially))
      (VP (VBN:[665..674] localized)
        (NP-1 (-NONE-:[674..674] *))
        (ADVP (RB:[675..689] longitudinally))
        (PP-LOC (IN:[690..696] within)
          (NP (DT:[697..700] the) (JJ:[701..706] small)
              (NN:[707..716] intestine)))
        (,:[716..717] ,)
        (PP (IN:[718..722] with)
          (NP
            (NP (DT:[723..726] the) (JJS:[727..734] highest)
                (JJ:[735..743] specific) (NN:[745..753] activity))
            (VP (VBG:[754..763] occurring)
              (PP-LOC (IN:[764..766] in)
                (NP
                  (NP (DT:[767..770] the) (NN:[771..777] region))
                  (PP
                    (NP-ADV
                      (QP (RB:[778..791] approximately)
                         (CD:[792..794] 15) (TO:[795..797] to)
                         (CD:[798..800] 30))
                      (NN:[801..803] cm))
                    (IN:[804..810] beyond)
                    (NP (DT:[811..814] the) (NN:[815..822] pylorus))))))))))
    (.:[822..823] .)))

;sentence 8 Span:825..935
;The effects of diet on the basal levels of heme oxygenase in the proximal
;small  intestine were also examined.
;[868..882]:substance:"heme oxygenase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[825..828] The) (NNS:[829..836] effects))
      (PP (IN:[837..839] of)
        (NP (NN:[840..844] diet)))
      (PP (IN:[845..847] on)
        (NP
          (NP (DT:[848..851] the) (JJ:[852..857] basal) (NNS:[858..864] levels))
          (PP (IN:[865..867] of)
            (NP (NN:[868..872] heme) (NN:[873..882] oxygenase)))
          (PP-LOC (IN:[883..885] in)
            (NP (DT:[886..889] the) (JJ:[890..898] proximal)
                (JJ:[899..904] small) (NN:[906..915] intestine))))))
    (VP (VBD:[916..920] were)
      (ADVP (RB:[921..925] also))
      (VP (VBN:[926..934] examined)
        (NP-1 (-NONE-:[934..934] *))))
    (.:[934..935] .)))

;sentence 9 Span:936..1317
;Although intestinal cytochrome P450-dependent  monooxygenase activity, as
;determined by benzo[a]pyrene hydroxylase and  7-ethoxycoumarin O-deethylase,
;was greatly reduced (65-90%) in animals  maintained on a semipurified control
;diet compared with standard cereal-based  chow, there were no differences
;observed in heme oxygenase activity between the  two dietary treatment
;groups.
;[956..971]:cyp450:"cytochrome P450"
;[983..996]:substance:"monooxygenase"
;[1024..1050]:substance:"benzo[a]pyrene hydroxylase"
;[1056..1085]:substance:"7-ethoxycoumarin O-deethylase"
;[1108..1114]:quantitative-value:"65-90%"
;[1193..1199]:substance:"cereal"
;[1207..1211]:substance:"chow"
;[1251..1265]:substance:"heme oxygenase"
(SENT
  (S
    (SBAR (IN:[936..944] Although)
      (S
        (NP-SBJ-1
          (NP (JJ:[945..955] intestinal)
            (ADJP
              (NML (NN:[956..966] cytochrome) (NN:[967..971] P450))
              (HYPH:[971..972] -) (JJ:[972..981] dependent))
            (NN:[983..996] monooxygenase) (NN:[997..1005] activity))
          (,:[1005..1006] ,)
          (SBAR (IN:[1007..1009] as)
            (S
              (NP-SBJ-2 (-NONE-:[1009..1009] *))
              (VP (VBN:[1010..1020] determined)
                (NP-2 (-NONE-:[1020..1020] *))
                (PP (IN:[1021..1023] by)
                  (NP-LGS
                    (NP (NN:[1024..1038] benzo-LSB-a-RSB-pyrene)
                        (NN:[1039..1050] hydroxylase))
                    (CC:[1051..1054] and)
                    (NP (NN:[1056..1072] 7-ethoxycoumarin)
                        (NN:[1073..1085] O-deethylase))))))))
        (,:[1085..1086] ,)
        (VP (VBD:[1087..1090] was)
          (ADVP (RB:[1091..1098] greatly))
          (VP (VBN:[1099..1106] reduced)
            (NP-1 (-NONE-:[1106..1106] *))
            (PRN (-LRB-:[1107..1108] -LRB-)
              (NP
                (QP (CD:[1108..1110] 65) (HYPH:[1110..1111] -)
                    (CD:[1111..1113] 90))
                (NN:[1113..1114] %))
              (-RRB-:[1114..1115] -RRB-))
            (PP-LOC (IN:[1116..1118] in)
              (NP
                (NP (NNS:[1119..1126] animals))
                (VP (VBN:[1128..1138] maintained)
                  (NP (-NONE-:[1138..1138] *))
                  (PP (IN:[1139..1141] on)
                    (NP (DT:[1142..1143] a) (JJ:[1144..1156] semipurified)
                        (NN:[1157..1164] control) (NN:[1165..1169] diet)))
                  (S-ADV
                    (NP-SBJ (-NONE-:[1169..1169] *))
                    (VP (VBN:[1170..1178] compared)
                      (PP (IN:[1179..1183] with)
                        (NP (JJ:[1184..1192] standard)
                          (ADJP (NN:[1193..1199] cereal) (HYPH:[1199..1200] -)
                                (VBN:[1200..1205] based))
                          (NN:[1207..1211] chow))))))))))))
    (,:[1211..1212] ,)
    (NP-SBJ (EX:[1213..1218] there))
    (VP (VBD:[1219..1223] were)
      (NP-PRD
        (NP
          (NP (DT:[1224..1226] no) (NNS:[1227..1238] differences))
          (PP-3 (-NONE-:[1238..1238] *ICH*)))
        (VP (VBN:[1239..1247] observed)
          (NP (-NONE-:[1247..1247] *))
          (PP (IN:[1248..1250] in)
            (NP
              (NML (NN:[1251..1255] heme) (NN:[1256..1265] oxygenase))
              (NN:[1266..1274] activity))))
        (PP-3 (IN:[1275..1282] between)
          (NP (DT:[1283..1286] the) (CD:[1288..1291] two)
              (JJ:[1292..1299] dietary) (NN:[1300..1309] treatment)
              (NNS:[1310..1316] groups)))))
    (.:[1316..1317] .)))

;sentence 10 Span:1318..1518
;The activity of intestinal heme oxygenase could be  increased, however, by
;oral treatment with several metal compounds that are  known to affect hepatic
;heme metabolism when administered parenterally.
;[1345..1359]:substance:"heme oxygenase"
;[1421..1436]:substance:"metal compounds"
;[1471..1475]:substance:"heme"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1318..1321] The) (NN:[1322..1330] activity))
      (PP (IN:[1331..1333] of)
        (NP (JJ:[1334..1344] intestinal)
           (NN:[1345..1349] heme) (NN:[1350..1359] oxygenase))))
    (VP (MD:[1360..1365] could)
      (VP (VB:[1366..1368] be)
        (VP (VBN:[1370..1379] increased)
          (NP-2 (-NONE-:[1379..1379] *))
          (,:[1379..1380] ,)
          (ADVP (RB:[1381..1388] however))
          (,:[1388..1389] ,)
          (PP (IN:[1390..1392] by)
            (NP-LGS
              (NP (JJ:[1393..1397] oral) (NN:[1398..1407] treatment))
              (PP (IN:[1408..1412] with)
                (NP
                  (NP (JJ:[1413..1420] several)
                     (NN:[1421..1426] metal) (NNS:[1427..1436] compounds))
                  (SBAR
                    (WHNP-1 (WDT:[1437..1441] that))
                    (S
                      (NP-SBJ-1 (-NONE-:[1441..1441] *T*))
                      (VP (VBP:[1442..1445] are)
                        (VP (VBN:[1447..1452] known)
                          (S
                            (NP-SBJ-1 (-NONE-:[1452..1452] *))
                            (VP (TO:[1453..1455] to)
                              (VP (VB:[1456..1462] affect)
                                (NP (JJ:[1463..1470] hepatic)
                                    (NN:[1471..1475] heme)
                                    (NN:[1476..1486] metabolism))
                                (SBAR-ADV
                                  (WHADVP-3 (WRB:[1487..1491] when))
                                  (S
                                    (NP-SBJ-4 (-NONE-:[1491..1491] *))
                                    (VP (VBN:[1492..1504] administered)
                                      (NP-4 (-NONE-:[1504..1504] *))
                                      (ADVP-MNR (RB:[1505..1517] parenterally))
                                      (ADVP-3 (-NONE-:[1517..1517] *T*)))))))))))))))))))
    (.:[1517..1518] .)))

;sentence 11 Span:1519..1634
;The  enzyme activity was also potently inhibited by tin (Sn4+) protoporphyrin
; administered orally or parenterally.
;[1524..1530]:substance:"enzyme"
;[1571..1596]:substance:"tin (Sn4+) protoporphyrin"
(SENT
  (S
    (NP-SBJ-1 (DT:[1519..1522] The) (NN:[1524..1530] enzyme)
              (NN:[1531..1539] activity))
    (VP (VBD:[1540..1543] was)
      (ADVP (RB:[1544..1548] also))
      (ADVP (RB:[1549..1557] potently))
      (VP (VBN:[1558..1567] inhibited)
        (NP-1 (-NONE-:[1567..1567] *))
        (PP (IN:[1568..1570] by)
          (NP-LGS
            (NP
              (NML
                (NML (NN:[1571..1574] tin))
                (NML (-LRB-:[1575..1576] -LRB-) (NN:[1576..1579] Sn4)
                     (SYM:[1579..1580] +) (-RRB-:[1580..1581] -RRB-)))
              (NN:[1582..1596] protoporphyrin))
            (VP (VBN:[1598..1610] administered)
              (NP (-NONE-:[1610..1610] *))
              (ADVP-MNR (RB:[1611..1617] orally) (CC:[1618..1620] or)
                        (RB:[1621..1633] parenterally)))))))
    (.:[1633..1634] .)))

;section 12 Span:1638..1682
;PMID: 2802622 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1638..1642] PMID) (::[1642..1643] :) (CD:[1644..1651] 2802622)
        (NN:[1652..1653] -LSB-) (NNP:[1653..1659] PubMed) (::[1660..1661] -)
        (NN:[1662..1669] indexed) (IN:[1670..1673] for)
        (NNP:[1674..1682] MEDLINE-RSB-)))
